Am Sciences

Developer of small molecule therapeutics for the treatment of Hepatitis-B

placeSeoul, Seoul, South Korea calendar_todayFounded 2016 groups9 employees language amsciences.co.kr

Innovation

7 patent families (3 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace accelerating. Cited 114 times.

YearFilings
20181
20193
20201
20211
20232
20244
20253

Investor mix

4 investors on record; lead investors include Premier Partners.

Investor typeCountShare
Venture capital250%
Private equity250%
Coming soon